Background: Patients with chronic kidney disease (CKD) and coincident heart failure with preserved ejection fraction (HFpEF) may constitute a distinct HFpEF phenotype. Osteopontin (OPN) is a biomarker of HFpEF and predictive of disease outcome. We recently reported that OPN blockade reversed hypertension, mitochondrial dysfunction, and kidney failure in Col4a3 mice, a model of human Alport syndrome.
Objectives: The purpose of this study was to identify potential OPN targets in biopsies of HF patients, healthy control subjects, and human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), and to characterize the cardiac phenotype of Col4a3 mice, relate this to HFpEF, and investigate possible causative roles for OPN in driving the cardiomyopathy.
Methods: OGDHL mRNA and protein were quantified in myocardial samples from patients with HFpEF, heart failure with reduced ejection fraction, and donor control subjects. OGDHL expression was quantified in hiPS-CMs treated with or without anti-OPN antibody. Cardiac parameters were evaluated in Col4a3 mice with and without global OPN knockout or AAV9-mediated delivery of 2-oxoglutarate dehydrogenase-like (Ogdhl) to the heart.
Results: OGDHL mRNA and protein displayed abnormal abundances in cardiac biopsies of HFpEF (n = 17) compared with donor control subjects (n = 12; p < 0.01) or heart failure with reduced ejection fraction patients (n = 12; p < 0.05). Blockade of OPN in hiPS-CMs conferred increased OGDHL expression. Col4a3 mice demonstrated cardiomyopathy with similarities to HFpEF, including diastolic dysfunction, cardiac hypertrophy and fibrosis, pulmonary edema, and impaired mitochondrial function. The cardiomyopathy was ameliorated by Opn coincident with improved renal function and increased expression of Ogdhl. Heart-specific overexpression of Ogdhl in Col4a3 mice also improved cardiac function and cardiomyocyte energy state.
Conclusions: Col4a3 mice present a model of HFpEF secondary to CKD wherein OPN and OGDHL are intermediates, and possibly therapeutic targets.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546303 | PMC |
| http://dx.doi.org/10.1016/j.jacc.2019.02.074 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of the Ocular Phenotype in a Col4a3 Knockout Mouse Model of Alport Syndrome.
Invest Ophthalmol Vis Sci
December 2024
Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States.
Purpose: Alport syndrome (AS) is a genetic condition caused by a dysfunctional collagen (IV) α3α4α5 heterotrimer, leading to basement membrane instability and, ultimately, abnormalities in the kidney, inner ear, and eyes. This study aimed to characterize ocular pathology of AS by focusing on inflammatory and fibrotic markers.
Methods: Col4a3tm1Dec knockout (KO) mice eyes were evaluated for the localization of collagen (IV) α3 and collagen (IV) α4, then stained for transforming growth factor-β1 (TGF-β1), TGF-β2, connective tissue growth factor (CTGF), and β-catenin.
Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.
Int J Mol Sci
August 2024
Division of Nephrology and Section of Mineral Metabolism, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Article Synopsis
- Chronic kidney disease (CKD) leads to various health issues, including high phosphate levels (hyperphosphatemia), which can harm blood vessels and cause muscle atrophy.
- In experiments with mice, those with CKD or high phosphate diets showed reduced muscle mass and function, confirming that hyperphosphatemia is linked to muscle damage.
- Direct exposure to high phosphate levels in cultured muscle cells also resulted in muscle atrophy, indicating that high phosphate can independently contribute to muscle injury, particularly in the context of CKD.
Chemical chaperones to the rescue of Alport syndrome?
Kidney Int
September 2024
Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Vanderbilt Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address:
Article Synopsis
- - Alport syndrome is a genetic kidney disease linked to mutations in collagen IV that disrupt the formation of a key protein complex in the kidney's structure.
- - Recent research by Yu et al. demonstrates that tauroursodeoxycholic acid, a chemical chaperone, can protect against kidney damage in mice with a specific Col4a3 mutation.
- - The treatment helps by boosting the deposition of the crucial protein complex in the kidney and stopping cell death in podocytes caused by stress on the endoplasmic reticulum.
Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitro.
Commun Biol
August 2024
Rare and Neurologic Diseases Research, Sanofi, Cambridge, MA, USA.
While significant advances have been made in understanding renal pathophysiology, less is known about the role of glycosphingolipid (GSL) metabolism in driving organ dysfunction. Here, we used a small molecule inhibitor of glucosylceramide synthase to modulate GSL levels in three mouse models of distinct renal pathologies: Alport syndrome (Col4a3 KO), polycystic kidney disease (Nek8), and steroid-resistant nephrotic syndrome (Nphs2 cKO). At the tissue level, we identified a core immune-enriched transcriptional signature that was shared across models and enriched in human polycystic kidney disease.
View Article and Find Full Text PDFCharacterization of Ocular Morphology in Col4a3-/- Mice as a Murine Model for Alport Syndrome.
Transl Vis Sci Technol
July 2024
Department of Ophthalmology, Peking University First Hospital, Xicheng District, Beijing, China.
Article Synopsis
- The study aimed to explore the eye-related characteristics and potential disease mechanisms in Col4a3-/- mice, which serve as a model for Alport syndrome (AS).
- Researchers examined collagen IV expression and performed various tests to analyze the structural integrity of different eye tissues, comparing Col4a3-/- mice with wild-type (WT) mice.
- Findings revealed significant ocular changes in Col4a3-/- mice, including thinner lens capsules, altered corneal structures, and enhanced Müller cell activation, suggesting parallels to AS in human patients and potential avenues for treatment research.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!